ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO883

IgA Nephropathy: A Timeline from Hematuria/Proteinuria to Nephrology Referral and Kidney Biopsy

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • AlShanableh, Zain, UPMC, Pittsburgh, Pennsylvania, United States
  • Ahmad, Syeda B., UPMC, Pittsburgh, Pennsylvania, United States
Background

IgA nephropathy (IgAN) is the most common cause of glomerulonephritis with hematuria being its hallmark finding. This study is aimed to look at the time between the development of hematuria and/or proteinuria and nephrology referral as well as time to biopsy.

Methods

We did a retrospective analysis of patients seen at UPMC seen by UPP nephrology who underwent a kidney biopsy from 1/1/20 to 3/13/24. The onset of hematuria and/or proteinuria was noted and compared to when the nephrology referral was made. The time in days between the first nephrology appointment and renal biopsy was also noted. Exclusion criteria were patients with secondary causes of IgA or those not seen by UPP nephrology.

Results

Preliminary data analysis revealed a total of 15 patients that were included. There were 8 men, 7 women, average age 43, 3 Asians and 12 Caucasians/White. Time between onset of hematuria/proteinuria to nephrology referrals ranged from 0 to 3633 days with a mean of 747 days. Whereas time between first nephrology encounter and biopsy ranged from 2 to 815 days with a mean of 149 days.

Conclusion

Recent data from UK registry indicates that patients with IgA nephrology and proteinuria have worse outcomes. With several novel treatments emerging for IgA Nephropathy, early referral and diagnosis is crucial to prevent progression to ESRD.